ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,687,000 | -40.2% | 68,201 | -16.0% | 0.00% | -100.0% |
Q4 2021 | $2,822,000 | +8.2% | 81,204 | -15.6% | 0.00% | 0.0% |
Q3 2021 | $2,609,000 | +3.2% | 96,195 | -1.3% | 0.00% | 0.0% |
Q2 2021 | $2,527,000 | +241.5% | 97,457 | +183.9% | 0.00% | – |
Q1 2021 | $740,000 | -10.4% | 34,333 | -10.6% | 0.00% | – |
Q4 2020 | $826,000 | +44.4% | 38,400 | -1.0% | 0.00% | – |
Q3 2020 | $572,000 | – | 38,784 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |